Home > Financial Ratios > SOLARA ACTIVE PHARMA SCIENCES

SOLARA ACTIVE PHARMA SCIENCES
Core EBITDA Margin

    Back to All Ratios
SOLARA ACTIVE PHARMA SCIENCES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SOLARA ACTIVE PHARMA SCIENCES
Please provide your vote to see the results

SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 16.07-7.389.276.3123.87

What is the latest Core EBITDA Margin ratio of SOLARA ACTIVE PHARMA SCIENCES ?

The latest Core EBITDA Margin ratio of SOLARA ACTIVE PHARMA SCIENCES is 16.07 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202516.07
Mar2024-7.38
Mar20239.27
Mar20226.31
Mar202123.87

How is Core EBITDA Margin of SOLARA ACTIVE PHARMA SCIENCES Trending?

Years Core EBITDA Margin % Change
Mar2025 16.07
Positive
Mar2024 -7.38
Negative
Mar2023 9.27
46.91
Mar2022 6.31
-73.57
Mar2021 23.87 -

Other Financial Ratios of SOLARA ACTIVE PHARMA SCIENCES


Compare Core EBITDA Margin ratio of peers of SOLARA ACTIVE PHARMA SCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES ₹2,406.4 Cr 2.8% 13.1% -0.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,937.0 Cr 1.2% -7% 2.5% Stock Analytics
DIVIS LABORATORIES ₹165,359.0 Cr 1.8% 2.7% 17% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,431.0 Cr 0.5% -4.8% 32.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,114.0 Cr 0.3% -4.5% 11.5% Stock Analytics
CIPLA ₹100,028.0 Cr 0.7% -5.8% -13.1% Stock Analytics


SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES

2.8%

13.1%

-0.1%

SENSEX

2.4%

3.2%

5.8%


You may also like the below Video Courses